GT Medicine SRL

GT Medicine reported total assets of 39,524 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).

Company number (CBE) 1029.430.811
1040 Etterbeek
active in Medical specialists activities (NACE 86220)
operating since 21 Oct 2025 (≈ 1 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of GT Medicine shows with a free account.

See the score
Profile
SRL since 2025
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result30,074 €
Equity31,074 €
Cash20,441 €
EBITDA37,785 €
Total assets39,524 €
The line marks its sector median: 67.6% (1599 companies).

Accounts of the company itself (not consolidated).

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

GT Medicine's annual accounts

2025
Net result30,074 €
Equity31,074 €
Cash20,441 €
EBITDA37,785 €
Total assets39,524 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 28 Jul 2026

GT Medicine's financial analysis

Management and control of GT Medicine

1 active director(s) in the register.

GT Medicine's shareholders and holdings →

GT Medicine's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
1029.430.811
VAT number
No VAT activity declared to the CBE
Peppol
Registered · 0208:1029430811 · as of 10 Nov 2026
Legal form
SRL
Incorporated
21 Oct 2025
Registered office
1040 Etterbeek
Latest accounts
2025 · filed on 28 Jul 2026
Activity
Medical specialists activities (NACE 86220)

GT Medicine (SRL) has been based in Etterbeek since 2025, active in: medical specialists activities. For 2025, it reports a net profit of 30,074 € and equity of 31,074 €; its revenue is not published. Its solvency stands at 78.6%, above the median of its sector (67.6%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to GT Medicine

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about GT Medicine

What is the revenue of GT Medicine?

GT Medicine files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of GT Medicine?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for GT Medicine. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE1029430811. Its company number (CBE) is 1029.430.811.

Where is the registered office of GT Medicine?

According to the CBE register, the registered office of GT Medicine is in 1040 Etterbeek.

What is the equity of GT Medicine?

At the close of the 2025 financial year, the equity of GT Medicine amounts to 31,074 €, a solvency of 78.6% of total assets.

Who manages GT Medicine?

The register lists 1 active mandates at GT Medicine. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of GT Medicine

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 01 Aug 2026

No credit card, no commitment.

What each plan unlocks →